Doctor profile · Federal record
Dr. DAVID COFFMAN, CRNP
Psychiatric/Mental Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · BIRMINGHAM, AL
- NPI 1578851739
- Accepts Medicare
- 16 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2200 LAKESHORE DR, STE 150
BIRMINGHAM, AL 352098803
(205) 871-6926
fax (205) 871-7981
Credentials & registration
- NPI registered
- July 2011 — 15 yrs on file
- Profile last updated
- February 10, 2015
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 363LP0808X — NUCC code
- State license (1)
- Alabama #1-033258
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578851739. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
284
Distinct HCPCS
2
Medicare allowed
$26,852
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 260 | 90 | $98 | |
90833 |
Psychotherapy with evaluation and management visit, 30 minutes | 24 | 15 | $56 |
In context: peer comparison
Among 15 peers in this city , average services per provider: 89. This provider delivers 3.2× the peer median.Open Payments
Industry payments received
All-time total
$2,651
Transactions
130
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $427.76 | |
| Corium, LLC | 10 | $250.57 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $244.82 | |
| Lundbeck LLC | 14 | $228.77 | |
| Otsuka America Pharmaceutical, Inc. | 11 | $225.47 | |
| Neurocrine Biosciences, Inc. | 9 | $222.02 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $189.85 | |
| Janssen Pharmaceuticals, Inc | 9 | $179.40 | |
| ABBVIE INC. | 18 | $172.59 | |
| Supernus Pharmaceuticals, Inc. | 8 | $147.74 | |
| Axsome Therapeutics, Inc. | 4 | $91.44 | |
| Teva Pharmaceuticals USA, Inc. | 5 | $78.52 | |
| Vanda Pharmaceuticals Inc. | 2 | $67.05 | |
| Alkermes, Inc. | 2 | $45.28 | |
| Noven Therapeutics, LLC | 2 | $44.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,396
Patients
670
Total drug cost
$88,038
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Quetiapine Fumarate | Generic | 379 | 63 | $8,109 |
| Duloxetine Hcl | Generic | 356 | 80 | $20,444 |
| Clonazepam | Generic | 321 | 47 | $3,063 |
| Alprazolam | Generic | 310 | 44 | $2,660 |
| Trazodone Hcl | Generic | 296 | 73 | $4,890 |
| Lorazepam | Generic | 205 | 37 | $1,856 |
| Lamotrigine | Generic | 202 | 42 | $3,500 |
| Escitalopram Oxalate | Generic | 191 | 43 | $2,189 |
| Mirtazapine | Generic | 185 | 39 | $3,286 |
| Fluoxetine Hcl | Generic | 174 | 39 | $2,843 |